1. Home
  2. RCON vs CNSY Comparison

RCON vs CNSY Comparison

Compare RCON & CNSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Recon Technology Ltd.

RCON

Recon Technology Ltd.

N/A

Current Price

$0.90

Market Cap

25.4M

Sector

Energy

ML Signal

N/A

Logo Cerenome Inc. Common Stock

CNSY

Cerenome Inc. Common Stock

N/A

Current Price

$1.65

Market Cap

20.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RCON
CNSY
Founded
2007
1996
Country
China
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.4M
20.6M
IPO Year
2008
2016

Fundamental Metrics

Financial Performance
Metric
RCON
CNSY
Price
$0.90
$1.65
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $27.75
AVG Volume (30 Days)
113.0K
★ 161.9K
Earning Date
09-30-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 87.61
EPS
★ N/A
N/A
Revenue
★ $6,430,788.00
$5,213,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$10.08
$414.61
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.02
$1.49
52 Week High
$6.42
$4.03

Technical Indicators

Market Signals
Indicator
RCON
CNSY
Relative Strength Index (RSI) 38.53 38.01
Support Level $0.79 $1.54
Resistance Level $1.04 $1.96
Average True Range (ATR) 0.11 0.17
MACD -0.01 0.04
Stochastic Oscillator 13.29 26.19

Price Performance

Historical Comparison
RCON
CNSY

About RCON Recon Technology Ltd.

Recon Technology Ltd provides automation systems, industrial equipment, and support services tailored for the oil and gas industry in China. The company's business spans key segments such as automation products and software, equipment and accessories, oilfield environmental protection, and platform outsourcing services. It generates the majority of its revenue by providing integrated automation services to Chinese petroleum companies at oilfields. Its key products and services include pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system. The company's operations are centered on servicing upstream clients throughout China, with some broader industrial automation solutions.

About CNSY Cerenome Inc. Common Stock

Cerenome Inc is a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted therapeutics, and artificial intelligence to improve outcomes for patients with central nervous system cancers. The Company's CNSide Diagnostics platform supports the detection, molecular characterization, and longitudinal monitoring of CNS cancers through cerebrospinal fluid-based testing. Its therapeutic platform, REYOBIQ (rhenium Re186 obisbemeda), is being evaluated in clinical trials for leptomeningeal metastases, recurrent glioblastoma, and pediatric brain cancers. The data & artificial intelligence platform is designed to integrate diagnostic, molecular, imaging, and clinical data into actionable insights that support precision oncology and therapeutic innovation.

Share on Social Networks: